• Users Online: 58
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2014  |  Volume : 34  |  Issue : 1  |  Page : 46-52

Chronic idiopathic urticaria: autologous skin tests and treatment

1 Department of Dermatology and Venereology, Faculty of Medicine, Tanta University, Tanta, Egypt
2 Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt

Correspondence Address:
Nahla R Ghaly
MD, Department of Dermatology & Venereology, Faculty of Medicine, Tanta University, 6111 Tanta
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1110-6530.137312

Rights and Permissions

Background Chronic urticaria is defined as urticaria persisting daily or almost daily for more than 6 weeks. It affects 0.1% of the population. Intradermal injection of autologous serum and plasma elicits a cutaneous reactivity in almost 45-60% of patients with chronic idiopathic urticaria (CIU). Activation of coagulation process seems to play an important role in the pathogenesis of CIU. Oral anticoagulant therapy has been shown to be effective in the treatment of CIU. Objective The aim of this study was to evaluate and compare autologous serum skin test (ASST) and autologous plasma skin test (APST) in the diagnosis of CIU and to determine the effect of treatment with antihistamine (loratadine) and anticoagulant (dipyridamole). Patients and methods This study included 30 patients suffering from CIU. All patients were subjected to intradermal testing with their serum (ASST) and their plasma (APST). The patients were classified into three equal groups, according to treatment: 10 patients were treated with loratidine, 10 patients were treated with dipyridamole, and 10 patients were treated with combination of loratidine and dipyridamole for 1 month. Follow-up for the three groups was carried out at the first, second, and fourth week of treatment evaluating the effectiveness and adverse effects of drugs. Assessment of the symptom score reduce index (SSRI) in positive and negative ASST and APST patients was evaluated. Results The ASST was positive in 40% of patients, whereas APST was positive in 90% of patients. Loratadine, dipyridamole, and combination of both were effective in the management of patients with CIU. However, best results occurred with combination of both. No serious side effects of treatment were encountered. Conclusion Both ASST and APST can be used for diagnostic purposes in patients with CIU. APST is superior to ASST in diagnosis of CIU. Combined treatment with antihistamines and anticoagulants provides an effective management of chronic urticaria in positive autologous serum and plasma skin tests patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded265    
    Comments [Add]    

Recommend this journal